Dermata Therapeutics Inc (DRMA : NASDAQ)
Common Stock
$0.91
USD
+0.25 (37.19%)
Last updated: 2026-10-15
Follow DRMA
DRMA
Dermata Therapeutics Inc
WealthAwesomePerformance
1 Day
+37.19%
1 Week
-14.95%
1 Month
-19.47%
YTD
-31.58%
Key Statistics
Market Cap
$3.29M
52W High
$4.35
52W Low
$0.60
P/E Ratio
-
50 Day MA
$1.23
200 Day MA
$1.40
Beta
0.66
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/15/2026 | $0.77 | $1.18 | $0.77 | $0.91 | $0.91 | 168,552,687 |
| 10/14/2026 | $0.86 | $0.86 | $0.60 | $0.66 | $0.66 | 325,621 |
| 10/13/2026 | $0.89 | $0.90 | $0.84 | $0.86 | $0.86 | 38,107 |
| 10/12/2026 | $1.00 | $1.01 | $0.89 | $0.89 | $0.89 | 37,663 |
| 10/9/2026 | $1.08 | $1.08 | $1.01 | $1.02 | $1.02 | 22,100 |
| 10/8/2026 | $1.10 | $1.10 | $1.05 | $1.07 | $1.07 | 6,937 |
| 10/7/2026 | $1.14 | $1.14 | $1.11 | $1.12 | $1.12 | 7,417 |
| 10/6/2026 | $1.12 | $1.15 | $1.11 | $1.13 | $1.13 | 29,585 |
| 10/5/2026 | $1.16 | $1.16 | $1.09 | $1.11 | $1.11 | 14,089 |
| 10/2/2026 | $1.16 | $1.16 | $1.08 | $1.10 | $1.10 | 17,600 |
Analyst Price Targets
Based on 1 analyst covering DRMA · as of Sep 17, 2026
Wall Street analysts forecast DRMA stock price to rise 339.6% over the next 12 months.
Consensus
Buy4.00 / 5.00
Avg. Target
US$4.00
+339.6% Upside
Current Price
US$0.91
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DRMA's historical volatility
30-Day Vol
131.4%
Annualized
90-Day Vol
111.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.86 | US$0.54 – US$1.35 |
| 60 trading days | US$0.81 | US$0.43 – US$1.53 |
| 90 trading days | US$0.76 | US$0.35 – US$1.67 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Dermata Therapeutics Inc
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-7.86M
- Profit Margin
- 0.00%
- ROE (TTM)
- -183.89%
- EPS (Diluted)
- -3.42
- Book Value
- 0.87
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About DRMA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| KNDI | Kandi Technologies Group Inc | $4.11 | +928.50% |
| ESLA | Estrella Immunopharma Inc. | $0.54 | +68.35% |
| SDST | Stardust Power Inc. | $0.04 | +55.38% |
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $1.36 | +49.70% |
| WETO | Webus International Limited Ordinary Shares | $1.22 | +46.88% |
| RITRF | Reitar Logtech Holdings Limited | $0.02 | +40.85% |
| LESLQ | Leslie's, Inc. | $0.03 | +35.75% |
| SVRE | SaverOne 2014 Ltd. American Depositary Shares | $1.65 | +35.25% |